Crossmark

Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy

Crossref DOI link: https://doi.org/10.1007/s00277-020-04274-1

Published Online: 2020-09-24

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ballo, Olivier https://orcid.org/0000-0003-1634-1988
Kreisel, Eva-Maria

Eladly, Fagr

Brunnberg, Uta

Stratmann, Jan

Hunyady, Peter

Hogardt, Michael

Wichelhaus, Thomas A.

Kempf, Volkhard A. J.

Steffen, Björn

Vehreschild, Joerg J.

Vehreschild, Maria J. G. T.

Finkelmeier, Fabian

Serve, Hubert

Brandts, Christian H.
Funding

Funding for this research was provided by:

Johann Wolfgang Goethe-Universität, Frankfurt am Main
License Information

Text and Data Mining valid from 2020-09-24

Version of Record valid from 2020-09-24
More Information

Article History

Received: 10 August 2020

Accepted: 17 September 2020

First Online: 24 September 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below